Twist Bioscience Corporation TWST Proceeds from exercises of stock options and other stock issuances
Proceeds from exercises of stock options and other stock issuances at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's proceeds from exercises of stock options and other stock issuances.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's proceeds from exercises of stock options and other stock issuances?
- Twist Bioscience Corporation (TWST) reported proceeds from exercises of stock options and other stock issuances of $1.79M in Q1 2026.
- How has Twist Bioscience Corporation's proceeds from exercises of stock options and other stock issuances changed year-over-year?
- Twist Bioscience Corporation's proceeds from exercises of stock options and other stock issuances increased by 131.7% year-over-year, from $772K to $1.79M.
- What is the long-term trend for Twist Bioscience Corporation's proceeds from exercises of stock options and other stock issuances?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's proceeds from exercises of stock options and other stock issuances has grown at a -10.5% compound annual growth rate (CAGR), from $14.56M to $9.34M.